JXN
Price
$130.17
Change
-$0.80 (-0.61%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
8.93B
20 days until earnings call
Intraday BUY SELL Signals
MET
Price
$99.73
Change
-$0.92 (-0.91%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
60.89B
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JXN vs MET

JXN vs MET Comparison Chart in %
View a ticker or compare two or three
VS
JXN vs. MET commentary
Oct 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JXN is a Hold and MET is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for JXN with price predictions
Oct 13, 2026

JXN's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for JXN moved out of overbought territory on September 08, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 instances where the indicator moved out of the overbought zone. In 30 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a move down at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 62 cases where JXN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.

The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JXN as a result. In 51 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for JXN turned negative on September 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 26 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

JXN moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for JXN crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JXN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

Bullish Trend Analysis

Following a +3.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where JXN advanced for three days, in 299 of 380 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

JXN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 187 of 271 cases where JXN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. JXN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.947) is normal, around the industry mean (1.355). JXN's P/E Ratio (144.846) is considerably higher than the industry average of (20.332). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). Dividend Yield (0.027) settles around the average of (0.037) among similar stocks. P/S Ratio (1.511) is also within normal values, averaging (1.303).

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for MET with price predictions
Oct 13, 2026

MET in +2.36% Uptrend, rising for three consecutive days on October 13, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MET as a result. In 44 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for MET just turned positive on October 08, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 31 of 52 cases over the following month. The odds of a continued upward trend are 60%.

MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MET entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.219) is slightly higher than the industry average of (1.355). P/E Ratio (18.356) is within average values for comparable stocks, (20.332). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.037) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MET: Fundamental Ratings
MET
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
29
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JXNMET
RSI
ODDS (%)
Bearish Trend 7 days ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 2 days ago
65%
Declines
ODDS (%)
Bearish Trend 8 days ago
63%
Bearish Trend 15 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 6 days ago
69%
Bearish Trend 2 days ago
43%
COMPARISON
Comparison
Oct 15, 2026
Stock price -- (JXN: $130.03 vs. MET: $99.72)
Brand notoriety: JXN: Not notable vs. MET: Notable
Both companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: JXN: 73% vs. MET: 123%
Market capitalization -- JXN: $8.93B vs. MET: $60.89B
JXN [@Life/Health Insurance] is valued at $8.93B. MET’s [@Life/Health Insurance] market capitalization is $60.89B. The market cap for tickers in the [@Life/Health Insurance] industry ranges from $228.36K to $140.68B. The average market capitalization across the [@Life/Health Insurance] industry is $18.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JXN’s FA Score shows that 1 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).

  • JXN’s FA Score: 1 green, 4 red.
  • MET’s FA Score: 3 green, 2 red.
According to our system of comparison, MET is a better buy in the long-term than JXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JXN’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).

  • JXN’s TA Score: 4 bullish, 5 bearish.
  • MET’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MET is a better buy in the short-term than JXN.

Price Growth

JXN (@Life/Health Insurance) experienced а -0.21% price change this week, while MET (@Life/Health Insurance) price change was +4.11% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was -1.30%. For the same industry, the average monthly price growth was -5.84%, and the average quarterly price growth was -4.89%.

Reported Earning Dates

JXN is expected to report earnings on Nov 03, 2026.

MET is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Life/Health Insurance (-1.30% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

View a ticker or compare two or three
JXN
Daily Signal:
Gain/Loss:
MET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNP39.680.32
+0.81%
CenterPoint Energy
JBSS66.740.23
+0.35%
John B Sanfilippo & Son
SITC3.02-0.04
-1.31%
SITE Centers Corp
BATRA55.09-2.59
-4.49%
Atlanta Braves Holdings
VWAV4.01-0.38
-8.66%
Visionwave Holdings Inc

JXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, JXN has been loosely correlated with LNC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if JXN jumps, then LNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JXN
1D Price
Change %
JXN100%
-0.24%
LNC - JXN
64%
Loosely correlated
+0.35%
CNO - JXN
61%
Loosely correlated
+0.39%
MET - JXN
57%
Loosely correlated
+0.48%
PRU - JXN
51%
Loosely correlated
+0.02%
FG - JXN
51%
Loosely correlated
+1.01%
More